Ligand-induced formation of transient dimers of mammalian 12/15-lipoxygenase: A key to allosteric behavior of this class of enzymes?
Mammalian lipoxygenases (LOXs) have been implicated in cellular defense response and are important for physiological homeostasis. Since their discovery, LOXs have been believed to function as monomeric enzymes that exhibit allosteric properties. In aqueous solutions, the rabbit 12/15‐LOX is mainly present as hydrated monomer but changes in the local physiochemical environment suggested a monomer–dimer equilibrium. Because the allosteric character of the enzyme can hardly be explained using a single ligand binding‐site model, we proposed that the binding of allosteric effectors may shift the monomer–dimer equilibrium toward dimer formation. To test this hypothesis, we explored the impact of an allosteric effector [13(S)‐hydroxyoctadeca‐9(Z),11(E)‐dienoic acid] on the structural properties of rabbit 12/15‐LOX by small‐angle X‐ray scattering. Our data indicate that the enzyme undergoes ligand‐induced dimerization in aqueous solution, and molecular dynamics simulations suggested that LOX dimers may be stable in the presence of substrate fatty acids. These data provide direct structural evidence for the existence of LOX dimers, where two noncovalently linked enzyme molecules might work in unison and, therefore, such mode of association might be related to the allosteric character of 12/15‐LOX. Introduction of negatively charged residues (W181E + H585E and L183E + L192E) at the intermonomer interface disturbs the hydrophobic dimer interaction of the wild‐type LOX, and this structural alteration may lead to functional distortion of mutant enzymes. Proteins 2011. © 2012 Wiley Periodicals, Inc.
Top-30
Journals
|
1
2
3
4
5
6
7
|
|
|
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
7 publications, 18.42%
|
|
|
International Journal of Molecular Sciences
3 publications, 7.89%
|
|
|
Journal of Medicinal Chemistry
2 publications, 5.26%
|
|
|
Archives of Biochemistry and Biophysics
2 publications, 5.26%
|
|
|
Biochemistry
2 publications, 5.26%
|
|
|
Gene
1 publication, 2.63%
|
|
|
Medicinal Chemistry
1 publication, 2.63%
|
|
|
Frontiers in Endocrinology
1 publication, 2.63%
|
|
|
Frontiers in Pharmacology
1 publication, 2.63%
|
|
|
Nature Reviews Drug Discovery
1 publication, 2.63%
|
|
|
PLoS ONE
1 publication, 2.63%
|
|
|
Biochemical and Biophysical Research Communications
1 publication, 2.63%
|
|
|
Redox Biology
1 publication, 2.63%
|
|
|
Biochimica et Biophysica Acta - General Subjects
1 publication, 2.63%
|
|
|
Polymer
1 publication, 2.63%
|
|
|
FEBS Letters
1 publication, 2.63%
|
|
|
FEBS Journal
1 publication, 2.63%
|
|
|
Physical Chemistry Chemical Physics
1 publication, 2.63%
|
|
|
Biopolymers and Cell
1 publication, 2.63%
|
|
|
Molecules
1 publication, 2.63%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 2.63%
|
|
|
Blood
1 publication, 2.63%
|
|
|
Journal of Molecular Biology
1 publication, 2.63%
|
|
|
Protein Science
1 publication, 2.63%
|
|
|
1
2
3
4
5
6
7
|
Publishers
|
2
4
6
8
10
12
14
16
|
|
|
Elsevier
16 publications, 42.11%
|
|
|
American Chemical Society (ACS)
4 publications, 10.53%
|
|
|
MDPI
4 publications, 10.53%
|
|
|
Wiley
4 publications, 10.53%
|
|
|
Frontiers Media S.A.
2 publications, 5.26%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 2.63%
|
|
|
Springer Nature
1 publication, 2.63%
|
|
|
Public Library of Science (PLoS)
1 publication, 2.63%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 2.63%
|
|
|
Institute of Molecular Biology and Genetics (NAS Ukraine)
1 publication, 2.63%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 2.63%
|
|
|
American Society of Hematology
1 publication, 2.63%
|
|
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.